36105972|t|Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies.
36105972|a|Targeting concomitantly cholinesterase (ChEs) and monoamine oxidases (MAO-A and MAO-B) is a key strategy to treat multifactorial Alzheimer's disease (AD). Moreover, it is reported that the expression of cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) is increased significantly in the brain of AD patients. Using the triazole of diclofenac 12 as a lead compound, we synthesized a variety of analogs as multipotent inhibitors concomitantly targeting COX-2, 5-LOX, AChE, BChE, MAO-A and MAO-B. A number of compounds showed excellent in vitro inhibition of the target biological macromolecules in nanomolar concentration. Compound 39 emerged as the most potent multitarget ligand with IC50 values of 0.03 muM, 0.91 muM, 0.61 muM, 0.01 muM 0.60 muM and 0.98 muM towards AChE, BChE, MAO-A, MAO-B, COX-2 and 5-LOX respectively. All the biologically active compounds were found to be non-neurotoxic and blood-brain barrier penetrant by using PAMPA assay. In a reversibility assay, all the studied active compounds showed reversibility and thus were found to be devoid of side effects. MTT assay results on neuroblastoma SH-SY5Y cells showed that the tested compounds were non-neurotoxic. An in vivo acute toxicity study showed the safety of the synthesized compounds up to a 2000 mg kg-1 dose. In docking studies three-dimensional construction and interaction with key residues of all the studied biological macromolecules helped us to explain the experimental results.
36105972	0	10	Diclofenac	Chemical	MESH:D004008
36105972	52	66	cholinesterase	Gene	590
36105972	87	103	cyclooxygenase-2	Gene	5743
36105972	108	122	5-lipoxygenase	Gene	240
36105972	144	163	Alzheimer's disease	Disease	MESH:D000544
36105972	190	198	toxicity	Disease	MESH:D064420
36105972	244	258	cholinesterase	Gene	590
36105972	260	264	ChEs	Gene	590
36105972	290	295	MAO-A	Gene	4128
36105972	300	305	MAO-B	Gene	4129
36105972	349	368	Alzheimer's disease	Disease	MESH:D000544
36105972	370	372	AD	Disease	MESH:D000544
36105972	423	439	cyclooxygenase-2	Gene	5743
36105972	441	446	COX-2	Gene	5743
36105972	514	516	AD	Disease	MESH:D000544
36105972	517	525	patients	Species	9606
36105972	537	545	triazole	Chemical	MESH:D014230
36105972	549	562	diclofenac 12	Chemical	-
36105972	669	674	COX-2	Gene	5743
36105972	676	681	5-LOX	Gene	240
36105972	683	687	AChE	Gene	43
36105972	689	693	BChE	Gene	590
36105972	695	700	MAO-A	Gene	4128
36105972	705	711	MAO-B.	Gene	4129
36105972	986	990	AChE	Gene	43
36105972	992	996	BChE	Gene	590
36105972	998	1003	MAO-A	Gene	4128
36105972	1005	1010	MAO-B	Gene	4129
36105972	1012	1017	COX-2	Gene	5743
36105972	1022	1027	5-LOX	Gene	240
36105972	1101	1111	neurotoxic	Disease	MESH:D020258
36105972	1155	1160	PAMPA	Chemical	-
36105972	1298	1301	MTT	Chemical	MESH:C070243
36105972	1319	1332	neuroblastoma	Disease	MESH:D009447
36105972	1333	1340	SH-SY5Y	CellLine	CVCL:0019
36105972	1389	1399	neurotoxic	Disease	MESH:D020258
36105972	1418	1426	toxicity	Disease	MESH:D064420
36105972	Negative_Correlation	MESH:D004008	5743
36105972	Association	MESH:D000544	590
36105972	Positive_Correlation	MESH:D000544	5743
36105972	Association	MESH:D000544	4128
36105972	Negative_Correlation	MESH:D004008	590
36105972	Negative_Correlation	MESH:D004008	240
36105972	Association	MESH:D000544	4129
36105972	Negative_Correlation	MESH:D004008	MESH:D000544
36105972	Association	MESH:D000544	240

